Communication

The Korean Academy of Science and Technology announced on the 20th that it had elected 28 full members for the year 2023 at the '2022 2nd...

[Medigate News Reporter Seo Min-ji] Although the number of patients with degenerative arthritis increases worldwide every year due to the...

"EST-P-EXO1" aims to regenerate damaged cartilage tissue and suppress pain Bio-venture Exostemtech has applied for the domestic clinical...

Daewoong's 'DW-MSC' exosome extraction, purification and joint development of new indications Daewoong Pharmaceutical will join hands...

[Anchor comment] Today's JumpUp Bio introduces Exostemtech, which develops stem cell exosome treatments. It aims to enter clinical trials...

[an interview, ceo] The "platform technology developing, producing some the natural add-on to the following some eksso eksso" joyongu...

Exostemtech, a bio-venture specializing in the development of exosome-based treatments, announced on the 26th that it has attracted 10...

Exostemtech, a bio-venture specializing in the development of exosome-based treatments, will begin clinical trials using cancer exosome...

Exostemtech, a new drug developer, announced on the 16th that it has received approval from the Ministry of Food and Drug Safety for...